[Translation] A randomized, double-blind, placebo-controlled, multicenter phase III clinical trial of Yigan Mingmu Oral Liquid in the treatment of alcoholic fatty liver disease (liver and kidney deficiency syndrome)
以安慰剂为对照,评价益肝明目口服液治疗酒精性脂肪肝(肝肾不足证)的有效性和安全性。
[Translation] To evaluate the efficacy and safety of Yigan Mingmu Oral Liquid in the treatment of alcoholic fatty liver (liver-kidney insufficiency syndrome) with placebo as control.